Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: Sunshine State Books, Lithia, FL, U.S.A.
hardcover. Condition: As New. Hardback--no flaws.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Language: English
Published by John Wiley and Sons Ltd, Hoboken, 2015
ISBN 10: 111997139X ISBN 13: 9781119971399
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
First Edition
Hardcover. Condition: new. Hardcover. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Reviews the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics Identifies key challenges to the commercialisation of stem cell technology and avenues to overcome problems in the pipeline Written by an expert team with extensive experience in the business, basic and applied science of stem cell researchThis comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Seller: Ubiquity Trade, Miami, FL, U.S.A.
Condition: New. Brand new! Please provide a physical shipping address.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 251.22
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Language: English
Published by John Wiley and Sons Ltd, 2015
ISBN 10: 111997139X ISBN 13: 9781119971399
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
Condition: New. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Editor(s): Vertes, Alain A.; Qureshi, Nasib; Caplan, Arnold I.; Babiss, Lee E. Num Pages: 776 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 252 x 195 x 40. Weight in Grams: 1486. . 2015. 1st Edition. Hardcover. . . . .
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 255.60
Quantity: Over 20 available
Add to basketCondition: New.
US$ 240.37
Quantity: Over 20 available
Add to basketCondition: New.
Language: English
Published by John Wiley and Sons Ltd, Hoboken, 2015
ISBN 10: 111997139X ISBN 13: 9781119971399
Seller: CitiRetail, Stevenage, United Kingdom
First Edition
US$ 255.62
Quantity: 1 available
Add to basketHardcover. Condition: new. Hardcover. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Reviews the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics Identifies key challenges to the commercialisation of stem cell technology and avenues to overcome problems in the pipeline Written by an expert team with extensive experience in the business, basic and applied science of stem cell researchThis comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Language: English
Published by John Wiley and Sons Ltd, 2015
ISBN 10: 111997139X ISBN 13: 9781119971399
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Editor(s): Vertes, Alain A.; Qureshi, Nasib; Caplan, Arnold I.; Babiss, Lee E. Num Pages: 776 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 252 x 195 x 40. Weight in Grams: 1486. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Language: English
Published by John Wiley and Sons Ltd, Hoboken, 2015
ISBN 10: 111997139X ISBN 13: 9781119971399
Seller: AussieBookSeller, Truganina, VIC, Australia
First Edition
Hardcover. Condition: new. Hardcover. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Reviews the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics Identifies key challenges to the commercialisation of stem cell technology and avenues to overcome problems in the pipeline Written by an expert team with extensive experience in the business, basic and applied science of stem cell researchThis comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.